Environmental factors in infertility.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 11100299)

Published in Clin Obstet Gynecol on December 01, 2000

Authors

K S Hruska1, P A Furth, D B Seifer, F I Sharara, J A Flaws

Author Affiliations

1: University of Maryland School of Medicine, Baltimore, Maryland 21201-1192, USA. hruska@umbi.umd.edu

Articles by these authors

Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res (1997) 4.89

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med (2001) 4.15

Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev (1998) 3.24

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet (2001) 2.82

Environmental toxicants and female reproduction. Fertil Steril (1998) 2.03

Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J Cell Biochem (1995) 1.93

Laparoscopy in 100 women with chronic pelvic pain. Obstet Gynecol (1984) 1.84

Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science (1996) 1.82

Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci U S A (1997) 1.80

The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilization. Fertil Steril (1997) 1.65

Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nat Genet (1999) 1.64

Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicol Sci (2000) 1.52

Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology (1995) 1.45

Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol (2000) 1.42

Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod (2005) 1.41

Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Toxicol Appl Pharmacol (1996) 1.39

The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol (1998) 1.29

Increased body mass index has a deleterious effect on in vitro fertilization outcome. J Assist Reprod Genet (2001) 1.27

Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res (1996) 1.25

Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene (2007) 1.24

Methoxychlor may cause ovarian follicular atresia and proliferation of the ovarian epithelium in the mouse. Toxicol Sci (2002) 1.23

Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril (1998) 1.19

Oxytocin and milk removal are required for post-partum mammary-gland development. Genes Funct (1997) 1.17

Effect of bcl-2 on the primordial follicle endowment in the mouse ovary. Biol Reprod (2001) 1.13

The Stat3/5 locus encodes novel endoplasmic reticulum and helicase-like proteins that are preferentially expressed in normal and neoplastic mammary tissue. Genomics (2001) 1.12

Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Differ (1996) 1.11

Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod (1994) 1.11

Low and high responders--at what levels of serum estradiol do things start to get fuzzy? Fertil Steril (1999) 1.10

Predictors of menopausal hot flashes. J Womens Health (1998) 1.10

Megestrol acetate and cachexia associated with human immunodeficiency virus (HIV) infection. Ann Intern Med (1989) 1.07

Facial and neck paresthesia associated with nafarelin administration. Fertil Steril (1991) 1.06

In utero and lactational treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs mammary gland differentiation but does not block the response to exogenous estrogen in the postpubertal female rat. Toxicol Sci (2001) 1.05

Bcl-2 gene family and related proteins in mammary gland involution and breast cancer. J Mammary Gland Biol Neoplasia (1999) 1.02

Methoxychlor causes mitochondrial dysfunction and oxidative damage in the mouse ovary. Toxicol Appl Pharmacol (2006) 1.01

Ovarian follicle development and transgenic mouse models. Hum Reprod Update (2006) 1.00

Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction. Fertil Steril (1997) 1.00

Relation of body mass and sex steroid hormone levels to hot flushes in a sample of mid-life women. Climacteric (2007) 0.99

Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies. Obstet Gynecol (2000) 0.99

Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril (1998) 0.98

Factors associated with determinants of sexual functioning in midlife women. Maturitas (2006) 0.97

Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene (2000) 0.97

Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res (1999) 0.96

Blood exposure in single versus double gloving during pelvic surgery. Am J Obstet Gynecol (1990) 0.96

Induction of cytotoxic T cell responses in newborn mice by DNA immunization. Vaccine (1997) 0.95

Correlates of sexual functioning among mid-life women. Climacteric (2007) 0.93

A pilot study of a headache program in the workplace. The effect of education. J Occup Environ Med (1999) 0.93

Induction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer and activator of transcription 5-dependent. Cancer Res (2000) 0.93

Maternal and neonatal morbidity associated with in vitro fertilization. J Pediatr (1995) 0.92

kappa B elements strongly activate gene expression in non-lymphoid cells and function synergistically with NF1 elements. Nucleic Acids Res (1989) 0.92

Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage. AIDS Res Hum Retroviruses (1990) 0.91

Nail pigmentation changes associated with azidothymidine (zidovudine). Ann Intern Med (1987) 0.91

Smad 3 may regulate follicular growth in the mouse ovary. Biol Reprod (2002) 0.90

A simplified method to prepare PCR template DNA for screening of transgenic and knockout mice. Contemp Top Lab Anim Sci (2001) 0.90

Ethnic differences in cancer mortality trends in the US, 1950-1992. Ethn Health (2001) 0.90

Hormone replacement therapy and breast cancer: a qualitative review. Obstet Gynecol (2001) 0.89

Diagnosis of systemic polyarteritis nodosa following total abdominal hysterectomy and bilateral salpingo-oophorectomy: a case report. Int J Gynecol Pathol (1986) 0.89

Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values? Fertil Steril (2000) 0.88

Cytoreduction of ovarian cancer with the Cavitron ultrasonic surgical aspirator. Obstet Gynecol (1988) 0.88

Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril (2000) 0.88

Activin A stimulates meiotic maturation of human oocytes and modulates granulosa cell steroidogenesis in vitro. Fertil Steril (1998) 0.87

Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertil Steril (2000) 0.86

Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells. Cell Growth Differ (1996) 0.86

Media coverage of women's health issues: is there a bias in the reporting of an association between hormone replacement therapy and breast cancer? J Womens Health Gend Based Med (2001) 0.85

Effects of ovarian source, patient age, and menstrual cycle phase on in vitro maturation of immature human oocytes. Fertil Steril (1998) 0.85

Follicular mechanisms associated with 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Reprod Toxicol (1996) 0.85

Salpingoscopy: light microscopic and electron microscopic correlations. Obstet Gynecol (1991) 0.85

Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil Steril (1998) 0.85

90-day feeding and one-generation reproduction study in Crl:CD BR rats with 17 beta-estradiol. Toxicol Sci (1998) 0.84

Ovarian volume and antral follicle counts as indicators of menopausal status. Menopause (2001) 0.84

Understanding mammary gland development through the imbalanced expression of growth regulators. Dev Dyn (1996) 0.84

Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice. Br J Cancer (2004) 0.83

WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis. Oncogene (2000) 0.82

Loss of cyclin D1 in concert with deregulated estrogen receptor alpha expression induces DNA damage response activation and interrupts mammary gland morphogenesis. Oncogene (2007) 0.82

Contribution of diminished ovarian reserve to hypofertility associated with endometriosis. J Reprod Med (2001) 0.82

Predicting probabilities of pregnancy and multiple gestation from in vitro fertilization--a new model. Obstet Gynecol (1998) 0.81

In vivo gene transfer by low-volume jet injection. Anal Biochem (2000) 0.80

Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Gynecol Oncol (1997) 0.80

Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells. Biochem Biophys Res Commun (1996) 0.80

Inter-laboratory control data for reproductive endpoints required in the OPPTS 870.3800/OECD 416 reproduction and fertility test. Birth Defects Res B Dev Reprod Toxicol (2009) 0.80

Ovarian volume and menopausal status. Menopause (2000) 0.79

Baseline ovarian cysts do not affect clinical response to controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril (1992) 0.79

The effects of endocrine disrupting chemicals on the ovary. Front Biosci (2002) 0.79

Water intoxication and hyponatremic encephalopathy from the use of an oxytocin nasal spray. A case report. J Reprod Med (1985) 0.79

Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urine. Am J Obstet Gynecol (1993) 0.79

Endocrinologic aspects of gestational trophoblastic diseases. Int J Fertil (1990) 0.78

The right time and place for molecular scissors. Nat Biotechnol (1999) 0.78

A combined cytogenetic and molecular approach for diagnosing delayed puberty. Clin Pediatr (Phila) (1996) 0.77

"Poor responders" to gonadotropins and levels of antibodies to Chlamydia trachomatis? Fertil Steril (1999) 0.77

Effects of raloxifene in postmenopausal women. N Engl J Med (1998) 0.77

Urine hCG beta-subunit core fragment, a sensitive test for ectopic pregnancy. J Clin Endocrinol Metab (1994) 0.77

Persistent ectopic pregnancy: an argument for heightened vigilance and patient compliance. Fertil Steril (1997) 0.77

Effects of hydrosalpinx on IVF outcome: the search goes on. Hum Reprod (1997) 0.77

Infertility treatment and informed consent: current practices of reproductive endocrinologists. Obstet Gynecol (1999) 0.77

Relaxin secretion in in vitro fertilization pregnancies. Am J Obstet Gynecol (1996) 0.76

Premature ovarian failure among hairdressers. Hum Reprod (2009) 0.76

Chemicals and menopause: effects on age at menopause and on health status in the postmenopausal period. J Womens Health (1999) 0.76

Effect of ceramide on intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells. Toxicol Sci (2000) 0.76

Low fibrinogen level: A predisposing factor for venous thromboembolic events with hormone replacement therapy. Am J Hematol (1999) 0.76